Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Soleno Therapeutics (SLNO) Preferred Dividend Payments (2016)

Soleno Therapeutics (SLNO) has disclosed Preferred Dividend Payments for 1 consecutive years, with $172.0 as the latest value for Q4 2016.

  • For Q4 2016, Preferred Dividend Payments changed N/A year-over-year to $172.0; the TTM value through Dec 2016 reached $3.7 million, changed N/A, while the annual FY2016 figure was $3.7 million, N/A changed from the prior year.
  • Preferred Dividend Payments hit $172.0 in Q4 2016 for Soleno Therapeutics, down from $3.7 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $3.7 million in Q3 2016 and bottomed at $172.0 in Q4 2016.